Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

13.71

-0.12 (-0.87%)

At close: Jan 30, 2026, 4:00 PM EST

13.75

+0.04 (0.29%)

After-hours: Jan 30, 2026, 7:56 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Novel Immunotherapies	10.59M
Novel Immunotherapies Growth	30.99%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	10.59M
United States Growth	30.99%